Comparison between Prince Pipes IPO and Rossari Biotech IPO.
Prince Pipes IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rossari Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Prince Pipes IPO is up to ₹500.00 Cr whereas the issue size of the Rossari Biotech IPO is up to ₹496.25 Cr. The final issue price of Prince Pipes IPO is ₹178.00 per share and of Rossari Biotech IPO is ₹425.00 per share.
| Prince Pipes IPO | Rossari Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹177.00 per share | ₹423.00 per share |
| Issue Price (Upper) | ₹178.00 per share | ₹425.00 per share |
| Issue Price (Final) | ₹178.00 per share | ₹425.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 84 shares | 35 shares |
| Fresh Issue Size | 1,40,44,943 shares | 11,76,470 shares |
| Fresh Issue Size (Amount) | up to ₹250.00 Cr | up to ₹50.00 Cr |
| OFS Issue Size | 1,40,44,942 shares | 1,05,00,000 shares |
| OFS Issue Size (Amount) | up to ₹250.00 Cr | up to ₹446.25 Cr |
| Issue Size Total | 2,80,89,885 shares | 1,16,76,470 shares |
| Issue Size Total (Amount) | up to ₹500.00 Cr | up to ₹496.25 Cr |
Prince Pipes IPO opens on Dec 18, 2019, while Rossari Biotech IPO opens on Jul 13, 2020. The closing date of Prince Pipes IPO and Rossari Biotech IPO is Dec 20, 2019, and Jul 15, 2020, respectively.
| Prince Pipes IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Dec 17, 2019 | Jul 10, 2020 |
| Issue Open | Dec 18, 2019 | Jul 13, 2020 |
| Issue Close | Dec 20, 2019 | Jul 15, 2020 |
| Basis Of Allotment (Tentative) | Dec 26, 2019 | Jul 20, 2020 |
| Initiation of Refunds (Tentative) | Dec 27, 2019 | Jul 21, 2020 |
| Credit of Share (Tentative) | Dec 30, 2019 | Jul 22, 2020 |
| Listing date (Tentative) | Dec 30, 2019 | Jul 23, 2020 |
| Anchor Lockin End date 1 | Jan 25, 2020 | Aug 19, 2020 |
| Anchor Lockin End date 2 | Mar 25, 2020 | Oct 18, 2020 |
Prince Pipes IPO P/E ratio is 18.35, as compared to Rossari Biotech IPO P/E ratio of 33.81.
| Prince Pipes IPO | Rossari Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 90.06 | 95.06 | ||||
| Promoter Shareholding (Post-Issue) | 65.80 | 73 | ||||
| P/E Ratio | 18.35 | 33.81 | ||||
| Market Cap | ₹1958.46 Cr. | ₹2207.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Prince Pipes IPO Retail Individual Investors (RII) are offered 98,31,460 shares while in Rossari Biotech IPO retail investors are offered 98,31,460 shares. Qualified Institutional Buyers (QIB) are offered 56,17,977 shares in Prince Pipes IPO and 23,35,294 shares in Rossari Biotech IPO.
| Prince Pipes IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 84,26,965 shares | 35,02,940 shares |
| Market Maker Reservation | ||
| QIB | 56,17,977 shares | 23,35,294 shares |
| NII | 42,13,483 shares | 17,51,471 shares |
| RII | 98,31,460 shares | 40,86,765 shares |
| Employee | ||
| Others | ||
| Total | 2,80,89,885 shares | 1,16,76,470 shares |
Prince Pipes IPO subscribed 2.21x in total, whereas Rossari Biotech IPO subscribed 79.37x.
| Prince Pipes IPO | Rossari Biotech IPO | |
|---|---|---|
| QIB (times) | 3.54x | 85.26x |
| NII (times) | 1.21x | 239.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.89x | 7.23x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.21x | 79.37x |
